Our feet work hard, so it's only fair to give them proper recovery time. These slides will help you do just that. Whether you’ve just finished an intense workout, stood for hours on end, or walked ...

PROGRAM THAT IS MAKING AN IMPACT. THIS IS WHAT RECOVERY LOOKS LIKE FOR TRAVIS MCCORD. HE’S WORKING ON THE FARM AT EVERGREEN GROVE IN GARDNER. IT’S MY BUDDY RIGHT HERE. CARING FOR ANIMALS AND HIMSELF.

Evergreen Grove is a long-term treatment community for substance abuse and mental health conditions Evergreen Grove is a long-term treatment community for substance abuse and mental health conditions ...

Boeing focuses on recovery, backlog, and certifying new models Boeing always watching market, developments to be ready to design new jet Rival Airbus leads in single-aisle jet orders in recent years ...

Remibrutinib is the first Bruton tyrosine kinase (BTK) inhibitor approved for chronic spontaneous urticaria, offering a novel treatment pathway by inhibiting BTK activity. Phase 3 trials showed ...

The NBA preseason tips off next week, and many players are debuting their latest basketball shoes. However, Golden State Warriors guard Jimmy Butler is making an even bolder move in the footwear ...

The 12-year-old girl who had a bullet lodged in her brain during the deadly shooting at a Minneapolis Catholic church is making a “miraculous” recovery, her family said. Seventh grader Sophia Forchas ...

Anyone can view a sampling of recent comments, but you must be a Times subscriber to contribute. Log in above or subscribe here. Conversations are opinions of our readers and are subject to the ...

For Morgan Cohen, the decision to try Kybella — an FDA-approved injectable treatment that helps the body break down the fat cells under the chin — came easily. When she posted a TikTok showing her ...

When many people hear the word recovery, they often think only of abstinence, a life free from alcohol or drugs. It tends to be centered on what we are leaving behind or what we are giving up. While ...

Omalizumab demonstrates superior symptom control in CSU, with 34%-44% achieving complete control in phase 3 trials. Dupilumab, an IL-4Rα antagonist, shows efficacy in CSU, particularly for patients ...